These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 194679)

  • 1. L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. An update of earlier findings and a comparison with those utilizing L-PAM plus 5-fluorouracil (5-FU).
    Fisher B; Glass A; Redmond C; Fisher ER; Barton B; Such E; Carbone P; Economou S; Foster R; Frelick R; Lerner H; Levitt M; Margolese R; MacFarlane J; Plotkin D; Shibata H; Volk H
    Cancer; 1977 Jun; 39(6 Suppl):2883-903. PubMed ID: 194679
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study.
    Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S
    Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy (CMFVP) versus L-phenylalanine mustard (L-PAM) for operable breast cancer with positive axillary nodes: a Southwest Oncology Group Study.
    Glucksberg H; Rivkin SE; Rasmussen S; Tranum B; Gad-el-Mawla N; Costanzi J; Hoogstraten B; Athens J; Maloney T; McCracken J; Vaughn C
    Cancer; 1982 Aug; 50(3):423-34. PubMed ID: 7046900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled study with 1-phenylalanine mustard (l-PAM) and 5-fluorouracil (5-FU) plus or minus prednisone in advanced breast cancer.
    Rossi A; Brambilla C; Bonadonna G
    Tumori; 1976; 62(2):193-6. PubMed ID: 1006810
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant combination chemotherapy in primary mammary carcinoma: the CMF program.
    Rossi A; Bonadonna G; Valagussa P; Veronesi U
    Recent Results Cancer Res; 1977; (62):134-42. PubMed ID: 341246
    [No Abstract]   [Full Text] [Related]  

  • 6. Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard.
    Canellos GP; Pocock SJ; Taylor SG; Sears ME; Klaasen DJ; Band PR
    Cancer; 1976 Nov; 38(5):1882-6. PubMed ID: 991103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute toxicity during adjuvant chemotherapy for breast cancer: the National Surgical Adjuvant Breast and Bowel Project (NSABP) experience from 1717 patients receiving single and multiple agents.
    Glass A; Wieand HS; Fisher B; Redmond C; Lerner H; Wolter J; Shibata H; Plotkin D; Foster R; Margolese R; Wolmark N
    Cancer Treat Rep; 1981; 65(5-6):363-76. PubMed ID: 7016322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer.
    Fisher B; Fisher ER; Redmond C
    J Clin Oncol; 1986 Jun; 4(6):929-41. PubMed ID: 3519883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-phenylalanine mustard (L-PAM) in the management of premenopausal patients with primary breast cancer: lack of association of disease-free survival with depression of ovarian function. National Surgical Adjuvant Project for Breast and Bowel Cancers.
    Fisher B; Sherman B; Rockette H; Redmond C; Margolese R; Fisher ER
    Cancer; 1979 Sep; 44(3):847-57. PubMed ID: 383274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A preliminary assessment of factors associated with recurrent disease in a surgical adjuvant clinical trial for patients with breast cancer with special emphasis on the aggressiveness of therapy.
    Ahmann DL; O'Fallon JR; Scanlon PW; Payne WS; Bisel HF; Edmonson JH; Frytak S; Hahn RG; Ingle JN; Rubin J; Creagan ET
    Am J Clin Oncol; 1982 Aug; 5(4):371-81. PubMed ID: 7051805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptichemio versus melphalan (L-PAM) in advanced breast cancer.
    Buzdar AU; Legha SS; Blumenschein GR; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Fraschini G; Bodey GP
    Cancer; 1982 May; 49(9):1767-70. PubMed ID: 7042074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant chemotherapy in the primary management of breast cancer.
    Fisher B
    Med Clin North Am; 1977 Sep; 61(5):953-65. PubMed ID: 330977
    [No Abstract]   [Full Text] [Related]  

  • 13. Adjuvant CMFVP versus melphalan for operable breast cancer with positive axillary nodes: 10-year results of a Southwest Oncology Group Study.
    Rivkin SE; Green S; Metch B; Glucksberg H; Gad-el-Mawla N; Constanzi JJ; Hoogstraten B; Athens J; Maloney T; Osborne CK
    J Clin Oncol; 1989 Sep; 7(9):1229-38. PubMed ID: 2671283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The case for local excision of breast cancer in selected cases.
    Crile G
    Lancet; 1972 Mar; 1(7750):549-51. PubMed ID: 4110046
    [No Abstract]   [Full Text] [Related]  

  • 15. The CMF program for operable breast cancer with positive axillary nodes. Updated analysis on the disease-free interval, site of relapse and drug tolerance.
    Bonadonna G; Rossi A; Valagussa P; Banfi A; Veronesi U
    Cancer; 1977 Jun; 39(6 Suppl):2904-15. PubMed ID: 326384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controversies in the management of potentially curable breast cancer.
    Wise L
    Surg Annu; 1974; 6():247-81. PubMed ID: 4215164
    [No Abstract]   [Full Text] [Related]  

  • 17. Repeated adjuvant chemotherapy with phenylalanine mustard or 5-fluorouracil, cyclophosphamide, and prednisone with or without radiation, after mastectomy for breast cancer.
    Ahmann DL; Scanlon PW; Bisel HF; Edmonson JH; Frytak S; Payne WS; O'Fallon JR; Hahn RG; Ingle JN; O'Connell MJ; Rubin J
    Lancet; 1978 Apr; 1(8070):893-6. PubMed ID: 76842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy in stage-II breast cancer: an overview of the NSABP clinical trials.
    Wolmark N; Fisher B
    Breast Cancer Res Treat; 1983; 3 Suppl():S19-26. PubMed ID: 6367856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mastectomy as an adjuvant to chemotherapy for locally advanced or metastatic breast cancer.
    Aisner J; Morris D; Elias EG; Wiernik PH
    Arch Surg; 1982 Jul; 117(7):882-7. PubMed ID: 6284089
    [No Abstract]   [Full Text] [Related]  

  • 20. L-Phenylalanine mustard (L-PAM) in the management of primary breast cancer. A report of early findings.
    Fisher B; Carbone P; Economou SG; Frelick R; Glass A; Lerner H; Redmond C; Zelen M; Band P; Katrych DL; Wolmark N; Fisher ER
    N Engl J Med; 1975 Jan; 292(3):117-22. PubMed ID: 1105174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.